Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,450.8
-30.3 (-1.22%)

 

  • STI Straits Times Index
    2,450.8
    -30.3 (-1.22%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,500.8
    4.3 (0.29%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,311.1
    -431.4 (-1.82%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,223.2
    -56.5 (-1.72%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,087.8
    -258.7 (-1.11%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,842.8
    -75.2 (-1.53%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,147.9M
  • Value: 1,185.0M
  • Rise: 88
  • Fall: 215
  • Unch: 479

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.144-0.007
Clearbridge0.172+0.016
Jiutian Chemical0.046-
Singtel2.120-0.080
AsiaMedic0.024+0.002
CWX Global0.001-
Biolidics0.370+0.055
Genting Sing0.670-0.010
ComfortDelGro1.420-0.040
NetLink NBN Tr0.950-

World Indices

World Indices
Name Last Change
Nasdaq 10,633.0 -330.6
HSI 23,311.1 -431.4
HSCEI 9,371.2 -187.6
Jakarta 4,842.8 -75.2
Nikkei 225 23,087.8 -258.7
SSE Comp 3,223.2 -56.5
Shanghai A 3,378.0 -59.3
Shanghai B 246.6 -3.4
KOSPI 2,272.7 -60.5

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

CELLDEX THERAPEUTICS INC CELLDEX THERAPEUTICS
Updated on 23 Sep 2020 (End of trading day)
Last (USD): 12.230 Change: -0.220 High: 13.330 Remarks: -
Change (%): -1.77 Low: 12.090
Open 12.390 Yesterday's Close 12.450000000000001
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 834,084 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.30035 Trailing EPS (USD) e -1.16330 NAV (USD) b 6.0942
PE a - Trailing PE f - Price / NAV b 2.0068
Dividend (USD) d - Cash In Hand (USD) g 1.7386 Issued & Paid-up Shares c 39,126,500
Dividend Yield (%) d - Price / Cash In Hand g 7.034 Treasury Shares h -
Market Cap (M) 478.517 Enterprise Value (M) 274.842
Piotroski F Score 0 Exchange Code CLDX Par Value ( $ ) n.a.
52 Weeks Volatility (%) 137.18 Free Float (%) 95.7
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 07 Aug 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CELLDEX THERAPEUTICS INC NASDAQ 478.517 - - 2.0068 -
Industry Medical Specialties NASDAQ 2,495.347 652.260 159.113 8.1574 0.036
Local Peer INTUITIVE SURGICAL INC NASDAQ 76,934.063 55.778 67.724 8.8020 -
Local Peer DEXCOM INC NASDAQ 36,963.191 365.610 180.573 27.3013 -
Local Peer IDEXX LABORATORIES INC NASDAQ 30,948.854 72.358 67.265 113.3799 -
Local Peer ALIGN TECHNOLOGY INC NASDAQ 24,291.515 54.862 14.278 8.5382 -
Local Peer GENMAB AS SPON ADS EACH REP 0.1 ORD SHS NASDAQ 23,580.053 72.620 28.186 8.7560 -
Local Peer HOLOGIC INC NASDAQ 16,510.294 - 25.008 7.3213 -
Local Peer INSULET CORPORATION NASDAQ 14,945.336 1,288.415 823.344 26.5317 -
Local Peer MASIMO CORPORATION NASDAQ 11,956.707 60.937 53.802 8.8927 -
Local Peer ABIOMED INC NASDAQ 11,717.253 57.718 73.845 10.6342 -
Local Peer NOVOCURE LTD NASDAQ 10,706.548 - 907.565 39.9766 -
Local Peer DENTSPLY SIRONA INC NASDAQ 9,336.334 35.513 - 2.0108 0.889
Local Peer QUIDEL CORP NASDAQ 8,231.029 112.876 53.208 13.4558 -
Other Local Peers TANDEM DIABETES CARE INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), BRUKER CORPORATION (NASDAQ), NEOGEN CORP (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), ICU MEDICAL INC (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), INARI MEDICAL INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), NUVASIVE INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), OUTSET MEDICAL INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), LIVANOVA PLC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), ATRICURE INC (NASDAQ), CAREDX INC (NASDAQ), BIOTELEMETRY INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), NANO-X IMAGING LTD (NASDAQ), INMODE LTD (NASDAQ), MESA LABORATORIES INC (NASDAQ), ATRION CORP (NASDAQ), CERUS CORP (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), HESKA CORP (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), VERICEL CORP (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), SI BONE INC (NASDAQ), INOGEN INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), ZYNEX INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), SURMODICS INC (NASDAQ), QUOTIENT LTD (NASDAQ), AXOGEN INC (NASDAQ), VIEWRAY INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), ANTARES PHARMA INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), CYTOSORBENTS CORP (NASDAQ), CUTERA INC (NASDAQ), PROFOUND MED CORP (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), IRADIMED CORP (NASDAQ), TELA BIO INC (NASDAQ), DERMTECH INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), MISONIX INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), SIENTRA INC (NASDAQ), FONAR CORP (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), SOLITON INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), DARIOHEALTH CORP (NASDAQ), INTRICOM CORP (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), PAVMED INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), NEURONETICS INC (NASDAQ), BIOMERICA INC (NASDAQ), ELECTROCORE INC (NASDAQ), CONFORMIS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), NEPHROS INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), TITAN MEDICAL INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), NEOVASC INC (NASDAQ), APPLIED UV INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), IMMUCELL CORP (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), NEUROTROPE INC (NASDAQ), BIOLASE INC (NASDAQ), CHF SOLUTIONS INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), IRIDEX CORP (NASDAQ), AVINGER INC (NASDAQ), CELSION CORPORATION (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), CYANOTECH CORP (NASDAQ), AETHLON MEDICAL INC (NASDAQ), CHECK-CAP LTD (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), DIGIRAD CORP (NASDAQ), NANOVIBRONIX INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), DYNATRONICS CORP (NASDAQ), CANCER GENETICS INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), NEUROMETRIX INC (NASDAQ)
Global Peer ABBOTT LABORATORIES NYSE 181,886.547 49.614 59.189 5.9483 1.279
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 166,448.028 45.035 44.913 5.5715 0.182
Global Peer DANAHER CORP NYSE 145,570.727 58.490 49.834 4.4120 0.325
Global Peer MEDTRONIC PLC NYSE 138,427.776 28.905 31.375 2.7523 2.170
Global Peer STRYKER CORP NYSE 76,022.654 36.497 47.484 5.9607 1.052
Global Peer BECTON DICKINSON & CO NYSE 65,391.548 60.436 84.485 2.7224 1.282
Global Peer BOSTON SCIENTIFIC CORP NYSE 53,964.872 11.482 13.559 3.4557 -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 47,283.403 45.165 63.587 12.3162 -
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 40,815.174 31.248 36.632 3.3181 2.041
Global Peer BAXTER INTERNATIONAL INC NYSE 39,653.153 39.614 42.915 4.8786 1.085
Other Global Peers AGILENT TECHNOLOGIES INC (NYSE), ALCON AG (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), COOPER COS INC (NYSE), TOPGLOV (Bursa), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), Top Glove (SGX), VARIAN MEDICAL SYSTEMS INC (NYSE), TELEFLEX INC (NYSE), BIO RAD LABORATORIES INC (NYSE), STERIS PLC (NYSE), PERKINELMER INC (NYSE), HARTA (Bursa), FISHER & PAYKEL HEALTHCARE CORP (ASX), WATERS CORP (NYSE), QIAGEN NV (NYSE), COCHLEAR LTD (ASX), WEIGAO GROUP (HKEx), PENUMBRA INC (NYSE), MICROPORT (HKEx), HILL-ROM HOLDINGS INC (NYSE), SUPERMX (Bursa), NEVRO CORP (NYSE), GLOBUS MED INC (NYSE), VENUS MEDTECH-B (HKEx), HAEMONETICS CORP (NYSE), ENVISTA HOLDINGS CORPORATION (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), KANGJI MEDICAL (HKEx), AK MEDICAL (HKEx), EBOS GROUP (ASX), PEIJIA-B (HKEx), CONMED CORP (NYSE), GLAUKOS CORPORATION (NYSE), CANTEL MEDICAL CORP (NYSE), AVANOS MEDICAL INC (NYSE), NANOSONICS LIMITED (ASX), CIRC (HKEx), LIFETECH SCI (HKEx), KDL MEDICAL (HKEx), CRYOLIFE INC (NYSE), VAPOTHERM INC (NYSE), INFUSYSTEM HOLDINGS INC (NYSE American), Medtecs Intl (SGX), YESTAR HEALTH (HKEx), MCP INCOME OPPORTUNITIES TRUST (ASX), UG Healthcare (SGX), GOLDEN MEDITECH (HKEx), PW MEDTECH (HKEx), CORMEDIX INC (NYSE American), AROA BIOSURGERY LTD (ASX), MEDICAL DEVELOPMENT INTL (ASX), INVACARE CORP (NYSE), STEREOTAXIS INC (NYSE American), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), ALPHA PRO TECH (NYSE American), RETRACTABLE TECHNOLOGIES INC (NYSE American), MODERN DENTAL (HKEx), ATOMO DIAGNOSTICS LIMITED (ASX), CYCLOPHARM LIMITED (ASX), EMVISION MEDICAL DEVICES LTD (ASX), SOMNOMED LIMITED (ASX), VINCENT MED (HKEx), RESPIRI LTD (ASX), LKL (Bursa), ELECTROMED INC (NYSE American), VOLITIONRX LIMITED (NYSE American), Biolidics (SGX), YUNNAN ENERGY (HKEx), SDI LTD (ASX), DAXOR CORP (NYSE American), RESAPP HEALTH LIMITED (ASX), COMPUMEDICS (ASX), IMAGION BIOSYSTEMS LIMITED (ASX), MICRO-X LTD (ASX), IMPEDIMED LIMITED (ASX), RESONANCE HEALTH LTD (ASX), MILESTONE SCIENTIFIC INC (NYSE American), KELFRED (HKEx), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), ONCOCYTE CORP (NYSE American), OPTISCAN IMAGING (ASX), NOVA EYE MEDICAL LIMITED (ASX), INCANNEX HEALTHCARE LTD (ASX), Yunnan Energy (SGX), DIMERIX LTD (ASX), CARDIEX LTD (ASX), OVENTUS MEDICAL LTD (ASX), LBT INNOVATIONS LTD (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), METALICITY LIMITED (ASX), USCOM LTD (ASX), RA MEDICAL SYSTEMS INC (NYSE), ADHERIUM LIMITED (ASX), XTANT MEDICAL HLDGS INC (NYSE American), ALLEGRA ORTHOPAEDICS LIMITED (ASX), Annica (SGX), STHAI (SET), LIFE HEALTHCARE (HKEx), HUAKANG BIOMED (HKEx), ANALYTICA (ASX), DORSAVI LTD (ASX), NEUROTECH INTERNATIONAL LTD (ASX), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.120
+0.99 %
10 Days -+0.520
+4.44 %
20 Days -+1.120
+10.08 %
Medium Term Return 3 Months --0.660
-5.12 %
6 Months -+10.440
+583.24 %
1 Year -+10.070
+466.20 %
Long Term Return 2 Years -+5.417
+79.51 %
3 Years --30.520
-71.39 %
5 Years --146.320
-92.29 %
Annualised Return Annualised --
-40.10 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.500 - 13.910 Change From 1 Year Low +10.730 % Change From 1 Year Low (%) +715.33
Change From 1 Year High -1.680 % Change From 1 Year High (%) -12.08
2 Years Range 1.500 - 13.910 Change From 2 Years Low +10.730 % Change From 2 Years Low (%) +715.33
Change From 2 Years High -1.680 % Change From 2 Years High (%) -12.08
5 Years Range 1.500 - 279.300 Change From 5 Years Low +10.730 % Change From 5 Years Low (%) +715.33
Change From 5 Years High -267.070 % Change From 5 Years High (%) -95.62
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.

Historical Price Data

Date Open High Low Close Volume VWAP
23 Sep 2020 12.390 13.330 12.090 12.230 834,084 -
22 Sep 2020 12.570 12.790 12.000 12.450 368,584 -
21 Sep 2020 12.850 12.894 12.330 12.520 742,303 -
18 Sep 2020 12.110 13.120 12.110 12.940 1,322,175 -
17 Sep 2020 11.670 12.580 11.522 12.110 480,022 -
16 Sep 2020 11.840 12.250 11.644 11.720 382,325 -
15 Sep 2020 12.670 13.000 11.560 11.730 562,061 -
14 Sep 2020 12.280 13.430 12.260 12.660 861,005 -
11 Sep 2020 11.720 12.250 11.720 12.010 311,957 -
10 Sep 2020 11.970 12.490 11.700 11.710 494,400 -
09 Sep 2020 11.440 12.170 11.440 11.990 954,398 -
08 Sep 2020 10.510 11.600 10.460 11.260 626,446 -
04 Sep 2020 11.030 11.390 10.260 10.680 796,856 -
03 Sep 2020 12.355 12.500 10.970 11.370 819,326 -
02 Sep 2020 11.960 12.820 11.820 12.470 831,515 -
01 Sep 2020 11.840 12.100 11.350 11.880 405,208 -
31 Aug 2020 12.060 12.120 11.380 11.940 438,117 -
28 Aug 2020 11.070 12.160 10.880 12.000 560,016 -
27 Aug 2020 11.300 11.360 10.917 11.110 695,947 -
26 Aug 2020 11.400 11.840 11.150 11.290 291,551 -
25 Aug 2020 11.110 11.460 10.930 11.440 384,743 -
24 Aug 2020 11.090 11.460 10.710 11.110 822,411 -
Summary
Current 2 Weeks
(10 Sep 2020 to 23 Sep 2020)
11.970 13.430 11.522 12.230 6,358,916 -
Previous 2 Weeks
(26 Aug 2020 to 09 Sep 2020)
11.400 13.430 11.150 11.990 6,419,380 -
4 Weeks from
(29 Jul 2020 to 25 Aug 2020)
11.150 13.430 9.590 11.440 11,400,122 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.